Terms of Service
Effective: May 17, 2026
Thank you for using AmaraCare. These Terms explain the agreement between you and Vestigo Partners, the company that operates AmaraCare. They are written to be readable on a phone. If something is unclear, email us at support@amaracare.ai.
A note about where we are. AmaraCare is an early-access product in MVP / closed-beta testing. Full HIPAA compliance is our target at general-availability launch. The contract work with our service providers (Business Associate Agreements), an independent security audit, formal penetration testing, and counsel review of the documents you are reading are all in progress and must complete before we open the service more broadly. The security and privacy practices we have already built today are listed in the Privacy Policy. Features will change as we learn. Behavior may be inconsistent at times. We are honest about this because we would rather you trust us than be surprised. Please read the Medical Safety Notice below carefully — that section does not change because we are early access.
1. Accepting these Terms
By creating an account or using AmaraCare, you agree to these Terms and to our Privacy Policy. If you do not agree, please do not use the service.
We may update these Terms over time. When we make a material change, we will notify active users and update the "Effective" date at the top. Continuing to use AmaraCare after a change means you accept the updated Terms.
2. What AmaraCare is
AmaraCare is a cancer care navigation tool. It uses AI to help you understand your diagnosis, organize your records, think through your options, and prepare for conversations with your care team.
Underneath the conversation you have with Amara, the platform maintains a structured record of your situation (a Patient Knowledge Graph), reads and organizes the documents you upload, and — for decision-grade questions — assembles a multi-specialist "Care Board" of AI agents (the Decision Clinic) that works through your case in real time and produces a Decision Packet you can read, push back on, and export as a PDF. The Care Board's reasoning is grounded in peer-reviewed evidence (PubMed, ClinicalTrials.gov, the FDA's drug data, the National Cancer Institute's treatment summaries, and a curated drug-facts registry traceable to FDA-approved labels). Four independent AI providers — Anthropic (Claude), OpenAI (used specifically as the cross-family Evidence Auditor in the Care Board, so the role that fact-checks claims comes from a different model family than the role that makes them), Groq (open-weight models and voice transcription), and Mistral (OCR for scanned documents) — handle different parts of the work. The Privacy Policy describes this architecture and what each provider sees.
AmaraCare is not a medical device, not a substitute for a licensed clinician, and not a replacement for the care you receive from your doctors, nurses, and treatment team.
3. Medical Safety Notice — please read carefully
AmaraCare provides health information and navigation support. It does not provide medical advice, diagnosis, or treatment. Any guidance the service shows you — including information about treatments, medications, clinical trials, side effects, or prognosis — is information to help you think and to prepare for conversations with your care team. It is not a recommendation that you act on without speaking to your clinicians.
You must discuss any treatment decision, medication change, clinical trial enrollment, or change to your care plan with your licensed clinicians before acting on it. If a piece of information from AmaraCare seems to disagree with your care team, your care team is the right source of truth. Bring the question to them.
Amara does not decide for you. On clinical questions where the evidence or your specific profile meaningfully tips the analysis, the service may surface that as a calibrated read with sources — so you can take it to your care team. On questions that depend on your values, the service stays neutral and helps you find your own answer. The goal is always to help you ask better questions, recognize what is urgent, and feel less alone — not to make your decisions for you.
If you are experiencing a medical emergency, call 911 (or your local emergency number) immediately. AmaraCare is not monitored in real time and does not dispatch emergency services.
If you are in emotional crisis or thinking about suicide, please reach out to people who can help: in the United States, call or text 988 for the Suicide and Crisis Lifeline, or text HOME to 741741 for the Crisis Text Line. AmaraCare will surface these resources in the product as well, but you should reach out directly.
4. Who can use AmaraCare
You must be 18 years of age or older to use AmaraCare. You must be located in the United States. You agree to give us accurate information about yourself (or, if you are a caregiver, about the person you are caring for).
One account is for one person. Please do not share your account credentials.
5. Early-access status and HIPAA target
AmaraCare is in MVP / closed-beta testing. Full HIPAA compliance is the goal at general-availability launch — not something we are setting aside, but a milestone we have not yet reached. The remaining work includes signing Business Associate Agreements with the AI providers that handle your information, completing an independent security audit, completing a formal penetration test, and having counsel finalize the documents you are reading. We are doing this work in parallel with building the product. The security and privacy practices we have already implemented today are listed in detail in the Privacy Policy.
By using the service in this MVP / beta state, you understand and accept that:
- Features will change over time, sometimes significantly.
- Behavior may be inconsistent — what worked yesterday may behave differently today.
- Information you provide is processed by third-party AI service providers under their standard commercial terms. We list those providers, what each one receives, and the typical retention windows in the Privacy Policy.
- You should not treat AmaraCare as your clinical system of record. It is a thinking and preparation tool, not a substitute for the records your care team keeps.
- We may pause, change, or remove features as we learn. We will give reasonable notice for changes that materially affect how you use the service.
If at any point the maturity of the service is not the right fit for you, you can close your account and request that we delete your information. We will help.
6. Your account
You are responsible for keeping your credentials confidential. If you believe your account has been accessed without your permission, please tell us at security@amaracare.ai as soon as you can.
You agree to keep the information in your account reasonably accurate. If something material changes (for example, a new diagnosis or a new treatment line), updating your information helps Amara help you.
If we have reason to believe an account has been compromised, we may temporarily suspend it and notify you so we can restore access safely.
7. How AI guidance works — and its limits
AmaraCare uses several AI models from independent providers, working together. Some reason about clinical questions. Some pull facts out of documents you upload. Others fact-check claims against published evidence. We deliberately mix providers so the system is less likely to make the same mistake twice — a citation that one model would fabricate, another model is more likely to catch. This is structural, not decorative: the Care Board's Evidence Auditor is deliberately run on a different AI company (OpenAI) than the rest of the panel (Anthropic and Groq), so the role that fact-checks claims doesn't share the same training and the same blind spots as the role that makes them.
The service is also wrapped in non-AI safeguards: every drug claim is grounded in a curated registry traceable to an FDA-approved drug label or a named clinical reviewer; generated responses are automatically scanned for hallucinated drug names, fabricated citations, and impossible numeric values (drug doses, lab ranges, biomarker percentages) before you see them; and a safety pipeline watches for crisis-language patterns and surfaces resources (988 Suicide and Crisis Lifeline, Crisis Text Line) when it sees them.
Even with all of that, AI can still be wrong. Evidence retrieval can miss a study. A model can misread a document. A specialist agent can attribute a finding to the wrong trial. We work continuously to reduce these errors, but you should know they can happen.
Because of this, the right way to use AmaraCare is as a tool that helps you think, prepare, and ask better questions of your care team — not as a source of medical decisions on its own. Treat AmaraCare's outputs the way you would treat a thoughtful, well-read friend who has read everything about your situation: useful for clarity and direction, never a substitute for the people who are actually caring for you.
8. Your content
You own the information you upload and the conversations you have with Amara. By using AmaraCare, you grant us a limited, non-exclusive license to process that content for the sole purpose of providing the service to you (and, where applicable, to your caregivers whom you have invited).
You can delete your content at any time. When you delete content or close your account, we remove it from active systems within 30 days, as described in the Privacy Policy.
We do not sell your content. We do not use your health information to train our own models. We do not opt in to training-data sharing with our AI service providers.
9. Acceptable use
To keep AmaraCare a safe, useful tool for everyone, you agree not to:
- Impersonate another person or misrepresent who you are.
- Use the service to make medical decisions without involving your care team.
- Use the service to circumvent or override the judgment of your treating clinicians.
- Upload content that you do not have the right to upload (for example, another person's medical records without their consent).
- Scrape, harvest, or use automated tools to extract content from AmaraCare beyond ordinary personal use.
- Attempt to probe, scan, or test the security of the service without our written permission.
- Resell, sublicense, or redistribute AmaraCare outputs for commercial purposes.
- Use the service to harass, defame, or harm any person.
If we believe in good faith that you have violated these limits, we may suspend or end your access. Where possible, we will tell you first and give you a chance to respond.
10. Intellectual property
The AmaraCare service — including our brand, code, model orchestration, prompts, evidence pipeline, and the design of the product — is owned by Vestigo Partners. We are not granting you any ownership interest in it by allowing you to use the service.
Your content — what you upload and write — remains yours. The license you grant us in Section 8 is the minimum needed to provide the service to you.
11. Service providers
We rely on a small number of service providers to run AmaraCare. They are listed in the Privacy Policy, along with what each one processes and how. By using AmaraCare, you understand that your information will be processed by those providers as described there.
12. Service is provided "as is"
AmaraCare is provided as is and as available. We do not warrant that the service will be uninterrupted, error-free, or always correct. We do not warrant the medical accuracy, completeness, or fitness for any particular medical purpose of any information the service shows you. The Medical Safety Notice in Section 3 is part of these warranties, not separate from them.
You use AmaraCare at your own discretion and assume the responsibility of discussing anything important with your care team before acting on it.
13. Limitation of liability (pending counsel review)
This section will set the limits on the financial responsibility AmaraCare can have for harms arising from your use of the service. The specific limits — including any cap, carve-outs for gross negligence or willful misconduct, and the treatment of indirect or consequential damages — will be finalized during counsel review and added in a future version. We are showing this section as a placeholder so you can see that it exists.
[Counsel review pending — limitation of liability text to be added.]
In the meantime, please re-read Sections 3, 7, and 12. The intent of this section is to make explicit, in legal terms, what those sections already say in plain language: AmaraCare is a thinking and preparation tool, not a clinical decision-maker, and decisions must rest with you and your care team.
14. Indemnification (pending counsel review)
This section will set the circumstances under which a user may be asked to defend AmaraCare against claims arising from misuse of the service (for example, claims by a third party whose records were uploaded without their consent). The specific scope of this commitment — including any carve-outs and procedural protections — will be finalized during counsel review.
[Counsel review pending — indemnification text to be added.]
15. Suspension, termination, and your right to leave
You may close your account at any time. Email support@amaracare.ai (or use the account-deletion option in the app once available) and we will help. As described in the Privacy Policy, we will remove your information from active systems within 30 days. We will give you a reasonable opportunity to export your information before final deletion.
We may suspend or end an account for:
- Material violation of these Terms (for example, a serious breach of Section 9 Acceptable Use).
- A credible security risk affecting the account or the service.
- Extended inactivity, after giving you notice and a chance to keep the account.
- A change in the service that requires winding down an account type (we will give reasonable notice).
When we end an account on our initiative, we will, where possible, give you notice, explain why, and provide a window to export your information.
16. Changes to these Terms
When we make a material change to these Terms, we will:
- Update the "Effective" date at the top and bump the version number.
- Notify active users — typically by an in-app banner and an email.
- Keep prior versions available in our documentation history.
Continuing to use AmaraCare after a material change means you accept the updated Terms. If you do not accept them, you can close your account.
17. Governing law and disputes (pending counsel review)
This section will set which jurisdiction's law governs these Terms, where disputes will be resolved (court venue and/or arbitration), and whether class actions are limited. These are decisions that should not be made casually; they will be set during counsel review.
[Counsel review pending — governing law and dispute-resolution text to be added.]
Until that section is finalized, if you have a concern or a dispute, please contact us first at support@amaracare.ai. We would rather resolve it directly than escalate.
18. How to reach us
For any question about these Terms or the service:
- Support:
support@amaracare.ai - Privacy questions:
privacy@amaracare.ai - Security reports:
security@amaracare.ai - Mailing address: available on request — email
support@amaracare.aiand we will provide it
19. Other
If any part of these Terms is found by a court to be unenforceable, the rest of the Terms remain in effect. Our failure to enforce a provision at any one time does not mean we are giving up the right to enforce it later. These Terms (together with the Privacy Policy) are the agreement between you and us about your use of AmaraCare.
Change log
| Date | Version | What changed |
|---|---|---|
| 2026-04-20 | 1 | Initial internal draft. Not published. Contained an ATTORNEY REVIEW banner and placeholder text for several sections. |
| 2026-05-17 | 2 | First version reachable from the live application. Expanded Medical Safety Notice and Section 7 (How AI guidance works and its limits) in patient-readable language. Added Section 5 (Early-access status). Added Section 15 (Suspension, termination, and your right to leave). Made placeholders explicit in Sections 13, 14, and 17 with one-sentence descriptions so users can see what each section is for. Counsel review still pending before general availability. |
| 2026-05-17 | 3 | Reframed the early-access notice and Section 5 to be explicit that full HIPAA compliance is the target at general-availability launch (not a position we are setting aside). Expanded Section 2 (What AmaraCare is) with an architecture summary so users understand the platform behind the conversation (Patient Knowledge Graph, document pipeline, Care Board, evidence sources, multi-provider AI). Expanded Section 7 (How AI guidance works) to name the multi-provider approach and the non-AI safeguards layered on top (Drug-Facts Authority grounded in FDA labels, post-generation hallucination scanning, crisis-language pipeline). Pointed readers to the Privacy Policy for the detailed security and PII practices list. |
| 2026-05-17 | 4 | Updated Section 2 (What AmaraCare is) to match the V4 Decision Clinic architecture: Care Board now described as a real-time panel that produces a Decision Packet you can read, push back on, and export as a PDF. Added OpenAI as a fourth AI service provider in Section 2, used specifically as the Care Board's cross-family Evidence Auditor. Expanded Section 7 (How AI guidance works) to explain that cross-family verification is structural, not decorative — the Evidence Auditor deliberately runs on a different AI company than the rest of the panel so the role that fact-checks claims doesn't share the same training and the same blind spots as the role that makes them. Added numeric-value checking (drug doses, lab ranges, biomarker percentages) to the non-AI safeguards list. |